Skip to main content
. Author manuscript; available in PMC: 2015 Dec 2.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2012 Mar 19;21(5):515–523. doi: 10.1002/pds.3249

Figure 2.

Figure 2

Mean difference in 12-month systolic BP among hypertensive diabetic patients initiated on a new OAD

Adjusted represents model 2 or 3 evaluating the effects of either sulfonylurea on Systolic BP or BMI change on systolic BP and adjusts for baseline covariates

* Adjusted + covariates + BMI change represents model 4 and includes both the OAD and the change in BMI.